MarketWatch Site Logo A link that brings you back to the homepage. [MarketWatch]
Atara Biotherapeutics, Inc. (ATRA)
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.atarabio.com/investor-relations
Company Research
Source: MarketWatch
The MarketWatch News Department was not involved in the creation of this content. MINNEAPOLIS & SOUTH SAN FRANCISCO, Calif., (BUSINESS WIRE) -- Be The Match BioTherapies and Atara Biotherapeutics, Inc. (Nasdaq: ATRA), today announced an extension of their collaboration to provide high-quality healthy donor cells for Atara's off-the-shelf T-cell immunotherapy platform for patients with cancer and autoimmune diseases. This multi-year partnership leverages the capabilities of Be The Match BioTherapies to source healthy donor cells from the Be The Match Registry ® with over 22 million genetically diverse human leukocyte antigen (HLA) immune profiles. “Atara and Be The Match BioTherapies share an aspiration to serve every patient, and this partnership will allow us to deliver treatments to the patient populations that our organization was founded to help,” said Chris McClain, Senior Vice President, Sales and Business Development at Be The Match BioTherapies. “We are proud to provide
Show less
Read more
Impact Snapshot
Event Time:
ATRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRA alerts
High impacting Atara Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ATRA
News
- Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress [Yahoo! Finance]Yahoo! Finance
- Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational ProgressBusiness Wire
- Atara Biotherapeutics, Inc. (NASDAQ: ATRA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Avenzo Therapeutics Announces $150 Million Oversubscribed Financing To Advance Emerging Oncology Pipeline [Yahoo! Finance]Yahoo! Finance
- Atara Biotherapeutics, Inc. (NASDAQ: ATRA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
ATRA
Earnings
- 3/28/24 - Beat
ATRA
Sec Filings
- 3/28/24 - Form 10-K
- 3/28/24 - Form 8-K
- 3/18/24 - Form SC
- ATRA's page on the SEC website